These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients. Everly MJ Clin Transpl; 2011; ():333-6. PubMed ID: 22755427 [TBL] [Abstract][Full Text] [Related]
23. Desensitization in the Setting of HLA-Incompatible Kidney Transplant. Malvezzi P; Jouve T; Noble J; Rostaing L Exp Clin Transplant; 2018 Aug; 16(4):367-375. PubMed ID: 29863455 [TBL] [Abstract][Full Text] [Related]
24. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R Clin Transpl; 2014; ():215-21. PubMed ID: 26281148 [TBL] [Abstract][Full Text] [Related]
25. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. Montgomery RA; Lonze BE; Jackson AM Curr Opin Organ Transplant; 2011 Aug; 16(4):439-43. PubMed ID: 21666478 [TBL] [Abstract][Full Text] [Related]
26. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553 [TBL] [Abstract][Full Text] [Related]
27. Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia. Idris MA; Hossain A; Muntasir MA; Marmi A; Aldajani AA; Aljamaan YM; Akhtar M; Housawi A Saudi J Kidney Dis Transpl; 2017; 28(3):499-506. PubMed ID: 28540885 [TBL] [Abstract][Full Text] [Related]
28. Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients. Khan MT; Hamid RB; Sarfaraz S; Lal N; Ahmed J; Luxmi S Saudi J Kidney Dis Transpl; 2020; 31(6):1432-1438. PubMed ID: 33565460 [TBL] [Abstract][Full Text] [Related]
29. Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation. Jordan SC; Reinsmoen N; Lai CH; Cao K; Kahwaji J; Peng A; Villicana R; Vo A Transplant Proc; 2012 Jan; 44(1):60-1. PubMed ID: 22310579 [TBL] [Abstract][Full Text] [Related]
30. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis. Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165 [TBL] [Abstract][Full Text] [Related]
33. Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization. Choi AY; Manook M; Olaso D; Ezekian B; Park J; Freischlag K; Jackson A; Knechtle S; Kwun J Front Immunol; 2021; 12():694763. PubMed ID: 34177960 [TBL] [Abstract][Full Text] [Related]
34. Editorial: Sensitization and Desensitization in Organ Transplantation. Anwar IJ; Jackson AM; Locke JE; Kwun J Front Immunol; 2021; 12():784472. PubMed ID: 34721444 [No Abstract] [Full Text] [Related]
35. Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation. Ajith A; Mulloy LL; Musa MA; Bravo-Egana V; Horuzsko DD; Gani I; Horuzsko A Front Immunol; 2021; 12():687715. PubMed ID: 34177940 [TBL] [Abstract][Full Text] [Related]
37. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching. Shang W; Dong L; Feng G; Wang Y; Pang X; Li J; Liu L; Zhang W J Int Med Res; 2013 Aug; 41(4):1333-41. PubMed ID: 23780877 [TBL] [Abstract][Full Text] [Related]
38. Desensitization protocols and their outcome. Marfo K; Lu A; Ling M; Akalin E Clin J Am Soc Nephrol; 2011 Apr; 6(4):922-36. PubMed ID: 21441131 [TBL] [Abstract][Full Text] [Related]
39. Sensitization and Desensitization in Vascularized Composite Allotransplantation. Moris D; Cendales LC Front Immunol; 2021; 12():682180. PubMed ID: 34456906 [TBL] [Abstract][Full Text] [Related]
40. [Desensitization protocols in immunized living donor kidney transplant recipients]. Nocera A G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]